Physician profile
Daniel Bailey
NPI 1982399382
$2,118.94
in general payments reported to CMS, 2019-2025
8 companies · $1,377 in 2025
The $1,377 reported for 2025 was more than what 91% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $381 · 2024: $361 · 2025: $1,377.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,119.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,118.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $752.53 | 2023-2025 | Mako, Gamma, T2 |
| Coastal Medical Technologies LLC | $310.83 | 2023-2025 | |
| Zimmer Biomet Holdings, INC. | $310.56 | 2024-2025 | Tapestry |
| Linvatec Corporation | $284.49 | 2025 | Biobrace 23mm, Linvatec Hip Preservation System |
| Medical Device Business Services, INC. | $220.83 | 2024-2025 | Vistaseal, Na, Actis |
| Vericel Corporation | $120.59 | 2024 | Maci |
| Polynovo North America LLC | $92.22 | 2024 | Novosorb Btm |
| Kci USA, INC. | $26.89 | 2023 | Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.